These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 1440349

  • 1. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
    Nikolaev AIu, Klepikov PV, Lashutin SV.
    Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma erythropoietin levels in patients undergoing long-term hemodialysis.
    Raich PC, Korst DR.
    Arch Pathol Lab Med; 1978 Feb; 102(2):73-5. PubMed ID: 579968
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Individual differences in the efficacy of Recormon in patients with terminal kidney failure. The role of iron deficiency].
    Nikolaev AIu, Klepikov PV, Lashutin SV, Kondakhchan MA, Rogov VA, Trofimova EI.
    Ter Arkh; 1993 Feb; 65(6):45-8. PubMed ID: 8378849
    [Abstract] [Full Text] [Related]

  • 7. [The abnormalities of blood cells in chronic kidney failure with long-term dialysis].
    Narita M, Shibata A.
    Nihon Rinsho; 1992 Jan; 50 Suppl():763-70. PubMed ID: 1578764
    [No Abstract] [Full Text] [Related]

  • 8. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
    Kühn K, Nonnast-Daniel B, Grützmacher P, Grüner J, Pfåffl W, Baldamus CA, Scigalla P.
    Contrib Nephrol; 1988 Jan; 66():94-103. PubMed ID: 3292152
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A, Barrau J, Gómez Alamillo C, Jaurrieta F.
    Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The effect of recombinant human erythropoietin on erythrocyte lines in patients with anemia and chronic renal insufficiency].
    Marisavljević D, Djukanović Lj, Lezajić V.
    Srp Arh Celok Lek; 1992 Feb; 120(9-10):281-5. PubMed ID: 1306020
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT.
    Contrib Nephrol; 1989 Feb; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
    Canaud B, Polito-Bouloux C, Rivory JP, Donnadieu P, Taib J, Florence P, Mion C.
    Nephrologie; 1990 Feb; 11(1):5-10. PubMed ID: 2374643
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.